the District of Delaware (the “Court”) entered the Order (I) Approving Bidding Procedures in
Summary
A First Supplemental Notice to Contract Parties of Potentially Assumed and Assigned Executory Contracts and Unexpired Leases, filed August 24, 2024 as Doc 462 in In re Vyaire Medical, Inc., et al., Case No. 24-11217 (BLS), in the U.S. Bankruptcy Court for the District of Delaware. It refers to the Bidding Procedures Order entered July 11, 2024 [Docket No. 249] and amends the debtors' first contract notice [Docket No. 256] to add newly discovered agreements and revise others. Counterparties to new contracts must object to cure amounts, assignment or adequate assurance by the later of September 6, 2024 or 14 calendar days after service. Exhibit A lists contracts with debtor entity, description and current cure amount, such as SunMed Group Holdings, LLC at $7,138,310.48. The notice is signed by the debtors' co-counsel, Cole Schotz P.C. and Kirkland & Ellis LLP.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Full text
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 1 of 10
IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE
)
In re: ) Chapter 11
)
VYAIRE MEDICAL, INC., et al.,1 ) Case No. 24-11217 (BLS)
)
Debtors. ) (Jointly Administered)
)
FIRST SUPPLEMENTAL NOTICE TO
CONTRACT PARTIES OF POTENTIALLY ASSUMED
AND ASSIGNED EXECUTORY CONTRACTS AND UNEXPIRED LEASES
YOU ARE RECEIVING THIS NOTICE BECAUSE YOU
OR ONE OF YOUR AFFILIATES IS A COUNTERPARTY TO AN
EXECUTORY CONTRACT OR UNEXPIRED LEASE WITH ONE OR MORE
OF THE DEBTORS AS SET FORTH ON EXHIBIT A ATTACHED HERETO.
PLEASE TAKE NOTICE that on July 11, 2024, the United States Bankruptcy Court for
the District of Delaware (the “Court”) entered the Order (I) Approving Bidding Procedures in
Connection With the Sale of Substantially All of the Debtors’ Assets, (II) Authorizing the Debtors
to Enter Into a Stalking Horse Agreement and Provide Bid Protections, (III) Approving the Form
and Manner of Notice Thereof, (IV) Scheduling an Auction and Sale Hearing, (V) Approving
Procedures for the Assumption and Assignment of Contracts, (VI) Approving the Sale of the
Debtors’ Assets Free and Clear, and (VII) Granting Related Relief [Docket No. 249] (the “Bidding
Procedures Order”).2
PLEASE TAKE FURTHER NOTICE that on July 11, 2024, the Debtors filed the First
Notice to Contract Parties of Potentially Assumed and Assigned Executory Contracts and
Unexpired Leases [Docket No. 256] (the “Initial Potentially Assumed and Assigned Contracts
Notice”), which included a list of Potentially Assumed and Assigned Contracts attached thereto as
Exhibit A.
PLEASE TAKE FURTHER NOTICE that, in accordance with the Bidding Procedures
Order and the approved contract designation process, the Debtors hereby file and provide notice
1 The last four digits of Debtor Vyaire Medical, Inc.’s federal tax identification number are 6495. A complete list
of each of the Debtors in these chapter 11 cases and each such Debtor’s federal tax identification number may be
obtained on the website of the Debtors’ claims and noticing agent at https://omniagentsolutions.com/Vyaire. The
location of Debtor Vyaire Medical, Inc.’s principal place of business and the Debtors’ service address in these
chapter 11 cases is 26125 North Riverwoods Boulevard, Mettawa, Illinois, USA 60045.
2 All capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Bidding
Procedures Order and the Initial Potentially Assumed and Assigned Contracts Notice, as applicable.
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 2 of 10
of supplemental changes made to the Initial Potentially Assumed and Assigned Contracts Notice,
as reflected in Exhibit A attached hereto.
PLEASE TAKE FURTHER NOTICE that the Potentially Assumed and Assigned
Contracts set forth on Exhibit A hereto reflect certain (a) additions of newly discovered
agreements (the “New Potentially Assumed and Assigned Contracts”) and (b) modifications to the
Initial Potentially Assumed and Assigned Contracts Notice in connection with certain Potentially
Assumed and Assigned Contracts (the “Revised Potentially Assumed and Assigned Contracts”).
PLEASE TAKE FURTHER NOTICE that the Initial Potentially Assumed and Assigned
Contracts Notice is hereby amended to include the New Potentially Assumed and Assigned
Contracts and to reflect the other modifications set forth in Exhibit A in connection with the
Revised Potentially Assumed and Assigned Contracts.
PLEASE TAKE FURTHER NOTICE that pursuant to the Bidding Procedures Order,
the Debtors may assume and assign to the Successful Bidders the New Potentially Assumed and
Assigned Contracts and the Revised Potentially Assumed and Assigned Contracts listed on
Exhibit A hereto to which you are a counterparty, upon the closing of the Sale Transactions. The
Debtors have conducted a review of their books and records and have determined that the cure
amount for unpaid monetary obligations under such Potentially Assumed and Assigned Contracts
is as set forth on Exhibit A attached hereto (the “Cure Amounts”).
PLEASE TAKE FURTHER NOTICE that if you are a counterparty to a New Potentially
Assumed and Assigned Contract and disagree with the proposed Cure Amounts, object to a
proposed assignment to a Successful Bidder of any such contract, or object to the ability of a
Successful Bidder to provide adequate assurance of future performance with respect to any such
contract, your objection must: (i) be in writing; (ii) comply with the applicable provisions of the
Bankruptcy Rules, Local Bankruptcy Rules, and any order governing the administration of these
chapter 11 cases; (iii) state with specificity the nature of the objection and, if the objection pertains
to the proposed Cure Amounts, state the correct cure amount alleged to be owed to the objecting
contract counterparty, together with any applicable and appropriate documentation in support
thereof; and (iv) be filed with the Court and served and actually received by the later of
(a) September 6, 2024 or (b) the date that is 14 calendar days after service of this notice
(the “Supplemental New Contract Objection Deadline”) by the Court and the following
parties: (i) co-counsel for the Debtors, Kirkland & Ellis LLP, 601 Lexington Avenue, New York,
New York 10022, Attn.: Joshua A. Sussberg, P.C. (joshua.sussberg@kirkland.com), Chris Ceresa
(chris.ceresa@kirkland.com), and Tiffani Chanroo (tiffani.chanroo@kirkland.com), and Kirkland
& Ellis LLP, 333 West Wolf Point Plaza, Chicago, Illinois 60654, Attn.: Spencer A. Winters, P.C.
(spencer.winters@kirkland.com) and Yusuf U. Salloum (yusuf.salloum@kirkland.com);
(ii) co˗counsel to the Debtors, Cole Schotz P.C., 500 Delaware Avenue, Suite 1410, Wilmington,
Delaware 19801, Attn: Patrick J. Reilley, Esq. (preilley@coleschotz.com), Michael E. Fitzpatrick,
Esq. (mfitzpatrick@coleschotz.com), and Jack M. Dougherty, Esq. (jdougherty@coleschotz.com),
and Cole Schotz P.C., Court Plaza North, 25 Main Street, Hackensack, New Jersey 07601, Attn.:
Michael D. Sirota, Esq. (msirota@coleschotz.com); and (iii) the Debtors’ investment banker, PJT
Partners LP, 280 Park Avenue, New York, New York 10017, Attn: Michael Schlappig
(schlappig@pjtpartners.com), Jaimie Baird (baird@pjtpartners.com), and Dylan Friesner
(friesner@pjtpartners.com) (iv) counsel to the 1L Ad Hoc Group, (a) Gibson, Dunn & Crutcher
2
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 3 of 10
LLP, 200 Park Avenue, New York, NY 10166-0193, Attn.: Scott J. Greenberg
(sgreenberg@gibsondunn.com), Jason Zachary Goldstein (jgoldstein@gibsondunn.com), Joshua
Brody (jbrody@gibsondunn.com), and Kevin Liang (kliang@gibsondunn.com) and (b) Pachulski
Stang Ziehl & Jones LLP, 919 North Market Street, 17th Floor, Wilmington, DE 19801, Attn.:
Laura Davis Jones (ljones@pszjlaw.com); (v) counsel to the Committee, McDermott Will &
Emery LLP, One Vanderbilt Avenue, New York, NY 10017-3852, Attn: Darren Azman
(dazman@mwe.com) and Kristin Going (kgoing@mwe.com), and McDermott Will & Emery
LLP, The Brandywine Building, 1000 N. West Street 1400, Wilmington, Delaware 19801, Attn:
David Hurst (dhurst@mwe.com) and Maris Kandestin (mkandestin@mwe.com); (vi) the United
States Trustee, 844 King Street, Suite 2207, Lockbox 35, Wilmington, Delaware 19801, Attn.:
Benjamin A. Hackman (benjamin.a.hackman@usdoj.gov). For the avoidance of doubt, the
Supplemental New Contract Objection Deadline applies solely to New Potentially Assigned
Contracts.
PLEASE TAKE FURTHER NOTICE that if no objection to (a) the Cure Amount(s),
(b) the proposed assignment and assumption of any Potentially Assumed and Assigned Contract,
or (c) adequate assurance of a Successful Bidder’s ability to perform is filed by the applicable
objection deadline, then you will be (i) deemed to have stipulated that the Cure Amounts as
determined by the Debtors are correct, (ii) forever barred, estopped, and enjoined from asserting
any additional cure amount under the Potentially Assumed and Assigned Contract, and (iii) forever
barred, estopped, and enjoined from objecting to such proposed assignment to the Successful
Bidder on the grounds that the Successful Bidder has not provided adequate assurance of future
performance as of the closing date of the Sale.
PLEASE THAT FURTHER NOTICE that, notwithstanding anything herein, the mere
listing of any Potentially Assumed and Assigned Contract, including any Revised Potentially
Assumed and Assigned Contract, on the schedule of potentially assigned contracts does not require
or guarantee that such Potentially Assumed and Assigned Contract will be assumed by the Debtors
at any time or assumed and assigned, and all rights of the Debtors and any Successful Bidder with
respect to such Executory Contracts and/or Unexpired Leases are reserved, including the Debtors’
ability to make other supplemental filings in connection with Potentially Assumed and Assigned
Contracts. Moreover, the Debtors explicitly reserve their rights, in their reasonable discretion, to
seek to reject or assume each Potentially Assumed and Assigned Contract, including any Revised
Potentially Assumed and Assigned Contract, pursuant to section 365(a) of the Bankruptcy Code
and in accordance with the procedures allowing the Debtors and/or the Successful Bidders to
designate any Potentially Assumed and Assigned Contract as either rejected or assumed on a post-
closing basis, or in accordance with the terms of the Debtors’ plan.
PLEASE TAKE FURTHER NOTICE that, nothing herein (i) alters in any way the
prepetition nature of the Potentially Assumed and Assigned Contracts or the validity, priority, or
amount of any claims of a counterparty to any Potentially Assumed and Assigned Contract against
the Debtors that may arise under such Potentially Assumed and Assigned Contract, (ii) creates a
postpetition contract or agreement, or (iii) elevates to administrative expense priority any claims
of a counterparty to any Potentially Assumed and Assigned Contract against the Debtors that may
arise under such Potentially Assumed and Assigned Contract.
3
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 4 of 10
PLEASE TAKE FURTHER NOTICE that you may obtain additional information
concerning the above-captioned chapter 11 cases at the website maintained in these chapter 11
cases at https://omniagentsolutions.com/Vyaire.
[Remainder of page intentionally left blank]
4
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 5 of 10
Dated: August 23, 2024
Wilmington, Delaware
/s/ Patrick J. Reilley
COLE SCHOTZ P.C. KIRKLAND & ELLIS LLP
Patrick J. Reilley, Esq. (DE Bar No. 4451) KIRKLAND & ELLIS INTERNATIONAL LLP
500 Delaware Avenue, Suite 1410 Joshua A. Sussberg, P.C. (admitted pro hac vice)
Wilmington, Delaware 19801 601 Lexington Ave
Telephone: (302) 652-3131 New York, New York 10022
Facsimile: (302) 652-3117 Telephone: (212) 446-4800
Email: preilley@coleschotz.com Facsimile: (212) 446-4900
Email: joshua.sussberg@kirkland.com
- and - - and -
Michael D. Sirota, Esq. (admitted pro hac vice) Spencer A. Winters, P.C. (admitted pro hac vice)
Warren A. Usatine, Esq (admitted pro hac vice) Yusuf U. Salloum (admitted pro hac vice)
Court Plaza North, 25 Main Street 333 West Wolf Point Plaza
Hackensack, New Jersey 07601 Chicago, Illinois 60654
Telephone: (201) 489-3000 Telephone: (312) 862-2000
Facsimile: (201) 489-1536 Facsimile: (312) 862-2200
Email: msirota@coleschotz.com Email: spencer.winters@kirkland.com
wusatine@coleschotz.com yusuf.salloum@kirkland.com
Co-Counsel to the Debtors Co-Counsel to the Debtors
and Debtors in Possession and Debtors in Possession
5
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 6 of 10
Exhibit A
First Supplemental Potentially Assumed and Assigned Contracts1
1 The inclusion of a contract on this list (each, a “Contract”) does not constitute an admission as to the executory
or non-executory nature of the Contract, or as to the existence or validity of any claims held by the counterparty
or counterparties to such Contract. The Debtors reserve all rights with respect to assumption or rejection of any
Contract included on this list.
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 7 of 10
Potentially Assumed and Assigned Contracts
Row # Unique Vendor Name Debtor Entity Description Current cure
96 ADP WorkforceNow Vyaire Medical, Inc. ADP 2017-04-20 Ariel-Vyaire Assignment $18,790.25
162 Aerotek, Inc. Vyaire Medical, Inc. Aerotek, Inc. 2021-07-02 MSA Exhibit A $595,394.48
Amazon Web Services, Inc. 2020-05-20 Enterprise
340 Amazon Web Services, Inc. Vyaire Medical, Inc. Agreement Addendum $690,468.17
541 Aryaka Networks, Inc. Vyaire Medical, Inc. Master Subscription Agreement $254,419.96
655 Augusta Hitech Soft Solutions LLC Vyaire Medical, Inc. Augusta
Baker Hitech
Tilly 2022-10-05
US LLP MSA
2022-09-13 Engagement Letter $1,893,923.38
719 Baker Tilly US, LLP Vyaire Medical, Inc. Amend #1 $62,147.94
Cleo Communications 2022-05-04 Master Relationship
1483 Cleo Communications US, LLC Vyaire Medical, Inc. Agreement $66,938.00
Cognizant Tech Solutions U.S. 2021-12-21 Extension
1511 Cognizant Worldwide Limited * Vyaire Medical, Inc. Agreement #5 $2,021,738.27
1618 Concur Technologies, Inc. Vyaire Medical, Inc. Concur 2017-02-21 IT Assignment & Assumption $32,942.48
Office Lease dated November 3, 2016 as amended or
otherwise modified by First Amendment to Lease dated
December 30, 2016, Second Amendment to Lease
dated January 19, 2022, Consent to Sublease dated
1949 DELL-METTAWA, LLC Vyaire Medical, Inc. January 19, 2022 and as otherwise modified. $269,816.78
2269 Emergo Global Consulting LLC Vyaire Medical, Inc. Emergo 2020-10-28 SOW Brazil $57,771.00
2365 Esker, Inc. Vyaire Medical, Inc. Esker 2022-09-01 IT Service Amend#2 $59,116.74
Exeter 6201 Global Distribution, Exeter 6201 Global Distribution LLC 2018-07-31
2434 LLC Vyaire Medical, Inc. Louisville Kentucky First Amendment to Lease $33,247.87
2528 Flexim Group SA Vyaire Medical, Inc. Flexim Group SA 2020-02-10 Service Agreement $215,173.10
Global Healthcare Exchange, LLC
2771 (GHX) Vyaire Medical, Inc. Global Healthcare Exchange, LLC 2017-09-30 IT SOW $167,097.53
2992 Healthtrust Vyaire Medical 211, Inc. Purchasing Agreement HPG-500084 $0.00
3005 Healthtrust Vyaire Medical, Inc. Purchasing Agreement HPG-4792 $103,419.51
Iron Mountain Information
3568 Management, LLC Vyaire Medical, Inc. Iron Mountain SOW of Records Management $0.00
3844 Kuehne + Nagel Inc. Vyaire Medical, Inc. Kuehne + Nagel Inc. 2019-06-01 Logistics Services $2,100,000.00
Microsoft Azure Service Volume Licensing Agreement
4624 Microsoft Corporation Vyaire Medical, Inc. E2473074 $58,232.41
Page 1 of 4
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 8 of 10
Row # Unique Vendor Name Debtor Entity Description Current cure
5368 Perma Pure LLC Vyaire Medical, Inc. Perma Pure LLC 2021-12-01 CDA $31,829.00
5437 Planful, Inc. Vyaire Medical, Inc. Planful 2022-03-01 Software Subscription $39,945.65
Premier Healthcare Alliance, L.P. (Scruggs, Wes) 2019-
5553 Premier Healthcare Alliance, L.P. Vyaire Medical, Inc. 10-02 CDA.pdf $0.00
Group Purchasing Agreement-Capital Equipment PP-NS-
5555 Premier Healthcare Alliance, L.P. Vyaire Medical 211, Inc. 1769 $11,321.71
Professional Registry Network dba
5677 PRN Staffing Vyaire Medical, Inc. PRN Staffing 2021-03-26 Service SOW#3 $36,225.00
5738 Prough, Kyle (Kyote Creative) Vyaire Medical, Inc. Kyote Creative 2017-11-02 Consulting Agreement $30,000.00
5934 Real Staffing Group Vyaire Medical, Inc. Real Staffing Group 2018-02-13 MSA T&Cs $180,854.75
RingCentral, Inc. 2020-06-11 IT Enterprise Support Serv
6083 RingCentral, Inc. Vyaire Medical, Inc. Attachment $257,369.06
6211 Saba Software, Inc. Vyaire Medical, Inc. Saba 2022-02-01 IT Order #2022-03-9576 $117,613.00
6469 SHOWPAD INC Vyaire Medical, Inc. Vendor/Supplier Master Service Agreement $36,824.00
6515 Silmates Private Limited Vyaire Medical, Inc. Silmates Private limited 2023-04-24 CDA $11,795.00
6648 Spark DSG LLC Vyaire Medical, Inc. Spark 2022-01-01 Second Amend to SOW $92,141.23
6797 SunMed Group Holdings, LLC Vyaire Medical, Inc. SunMed 2023-07-01 Contract Manufacturing Agreement $7,138,310.48
7235 Totex Manufacturing Vyaire Medical, Inc. Totex Manufacturing 2021-03-02 CDA $74,503.00
7587 Vertex, Inc. Vyaire Medical, Inc. Vertex, Inc. 2020-08-21 Master Agreement $37,921.00
Capital Equipment Supplier Agreement for Ventilators
7737 Vizient Supply, LLC Vyaire Medical, Inc. CE7312 $0.00
Capital Equipment Supplier Agreement for Ventilators
7751 Vizient Supply, LLC Vyaire Medical, Inc. CE7298 $242,413.85
8098 Workday, Inc. ** Vyaire Medical, Inc. Workday, Inc. 2022-09-26 IT Exhibit Amendment $1,738.53
Xerox Financial Services LLC 2017-02-16 IT Lease
8135 Xerox Financial Services LLC Vyaire Medical, Inc. (Mettawa).pdf $87,224.68
8159 Yusen Logistics (Americas) Inc. Vyaire Medical, Inc. Yusen Logistics (Americas) Inc. 2020-12-23 CDA $0.00
8199 Zensar Technologies Inc. Vyaire Medical, Inc. Zensar 2021-04-15 MSA SOW Change Order $41,091.00
Airgas USA, LLC 2017-11-02 Agreement for Supply of
8241 Airgas USA, LLC Vyaire Medical, Inc. CylinderProducts and Related Equipment $40,556.48
8242 Corday, Stephen MD Vyaire Medical, Inc. Corday, Stephen MD 2020-12-07 ES #73408 $0.00
8243 Data Modul Vyaire Medical, Inc. PS070633 $19,057.50
Page 2 of 4
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 9 of 10
Row # Unique Vendor Name Debtor Entity Description Current cure
8244 Data Modul Vyaire Medical, Inc. PS070646 $145,292.00
8245 Data Modul Vyaire Medical, Inc. PS070620 $150,099.60
8246 Data Modul Vyaire Medical, Inc. PS070620 $50,033.20
8247 Data Modul Vyaire Medical, Inc. 46103967 $5,250.00
8248 David, Marian MD Vyaire Medical, Inc. David, Marian MD 2019-12-05 ES #71301 $0.00
Ewald Fleet Solutions, LLC 02-13-2019 Master Lease
8249 Ewald Fleet Solutions, LLC Vyaire Medical, Inc. Agreement No.19-17941 $0.00
8250 Healthtrust Vyaire Medical, Inc. Purchasing Agreement HPG-4792 $0.00
Iron Mountain Information
8251 Management, LLC Vyaire Medical, Inc. Iron Mountain 2012-01-01 Master Service Agreement $0.00
Iron Mountain Information Iron Mountain 2012-01-01 Service CareFusion
8252 Management, LLC Vyaire Medical, Inc. Affiliate/Multi-Location Agreement $0.00
Iron Mountain Information Iron Mountain 2012-01-01 Service Bloomington
8253 Management, LLC Vyaire Medical, Inc. Affiliate/Multi-Location Agreement $0.00
8260 Microsoft Licensing, GP Vyaire Medical, Inc. Microsoft Licensing, GP 2009-12-04 IT Service $0.00
8261 Perma Pure LLC Vyaire Medical, Inc. 2015-01-26 Tool Supply Contract $0.00
Group Purchasing Agreement-Capital Equipment PP-NS-
8262 Premier Healthcare Alliance, L.P. Vyaire Medical 211, Inc. 1769 $0.00
8263 Proctor, Steven MD Vyaire Medical, Inc. Proctor, Steven MD 2020-08-13 ES #73006 $0.00
8264 Prosymmetry LLC Vyaire Medical, Inc. Prosymmetry 2023-12-04 Order Form $52,616.40
8265 salesforce.com, inc. Vyaire Medical, Inc. Purchase Order Quote Q-07842041 $0.00
8266 salesforce.com, inc. Vyaire Medical, Inc. Purchase Order Quote Q-07187278 $0.00
8267 salesforce.com, inc. Vyaire Medical, Inc. Purchase Order Quote Q-07114790 $0.00
8268 Singh, Shivani MD (South Africa) Vyaire Medical, Inc. Singh, Shivani 2022-09-01 HCP Qualification Form $0.00
Suh, Gee Young 2021-04-14 HCP Agreement Ends 2022-
8269 Suh, Gee Young MD (South Korea) Vyaire Medical, Inc. 04-30 $0.00
8270 SunMed Holdings, LLC Vyaire Medical, Inc. SunMed 2016-05-05 Distribution (Ventlabs) Agreement $0.00
8271 SunMed Holdings, LLC Vyaire Medical, Inc. SunMed 2016-03-09 Non-circumvent Agreement $0.00
SunMed 2021-01-08 Distribution Non-circumvent
8272 SunMed Holdings, LLC Vyaire Medical, Inc. Amendment $0.00
Capital Equipment Supplier Agreement for Ventilators
8274 Vizient Supply, LLC Vyaire Medical, Inc. CE7298 $0.00
Page 3 of 4
Case 24-11217-BLS Doc 462 Filed 08/24/24 Page 10 of 10
Row # Unique Vendor Name Debtor Entity Description Current cure
Workday Production Support and Service Level
8275 Workday, Inc. Vyaire Medical, Inc. Availability Policy (SLA) $0.00
8276 Workday, Inc. Vyaire Medical, Inc. Workday Security Exhibit $0.00
Zensar 2022-11-23 Change Request for ADM
8277 Zensar Technologies Inc. Vyaire Medical, Inc. Applications Support $24,300.00
Zensar 2022-10-22 Change Request for SAP
8278 Zensar Technologies Inc. Vyaire Medical, Inc. Applications Support $35,366.00
8279 Zensar Technologies Inc. Vyaire Medical, Inc. Zensar 2023-12-15 Change Order and Amendment $1,256,416.00
Zensar 2023-11-14 Change Request for SAP
8280 Zensar Technologies Inc. Vyaire Medical, Inc. Applications Support $154,484.00
Zensar 2023-11-15 Change Request for ADM
8281 Zensar Technologies Inc. Vyaire Medical, Inc. Applications Support $97,204.00
8282 Zensar Technologies Inc. Vyaire Medical, Inc. Zensar Purchase Order 4201090861 $16,009.34
8283 Zensar Technologies Inc. Vyaire Medical, Inc. Zensar Purchase Order 4201090887 $6,425.35
Zensar 2024-04-18 Zensar Vyaire SOC as a Service for
8284 Zensar Technologies Inc. Vyaire Medical, Inc. the period May 2024 till Sept 2025 $28,065.70
Zensar 2024-04-18 Zensar Vyaire Infra Support for the
8285 Zensar Technologies Inc. Vyaire Medical, Inc. period May 2024 till Sept 2025 $147,820.40
Footnotes
* For Cognizant: The list of documents set forth in this Second Notice to Contract Parties of Potentially Assumed and Assigned Executory Contracts and
Unexpired Leases with respect to Cognizant Worldwide Limited and Cognizant Technology Solutions U.S. Corp. are not intended by the Debtors to suggest that
each document is a separate executory contract, each of the documents is in connection with the Cognizant’s Master Services Agreement with the Debtors.
** For Workday: The current Workday contracts and order forms, which are integrated agreements, comprise: 1) Master Service Agreement, (2) Order Form
#00401133.0, and (3) Order Form #00256180.0. The Workday cure amount is $1,738.53
Page 4 of 4
File and source
- File
- gov.uscourts.deb.193283.462.0.pdf
- Size
- 286,672 bytes
- SHA-256
- 587f2a5b304694165db57e2e14a9dd951219f6f79aab23233c5628b2f8aa6447
- Original
- PACER (login required)